Results 271 to 280 of about 161,275 (301)
Some of the next articles are maybe not open access.
Induction of interleukin-1 and interleukin-1 receptor antagonist.
Seminars in oncology, 1997Drugs that affect the production or action, or both, of the pleiotropic inflammatory cytokine interleukin-1 (IL-1) are predicted to have a significant impact on a variety of human diseases. The biochemical properties of IL-1 and the IL-1 receptor antagonist, the mechanism for their production, and the factors that regulate their release are discussed ...
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
New England Journal of Medicine, 2021Anthony C Gordon +2 more
exaly
INTERLEUKIN 1 RECEPTOR ANTAGONIST
World Journal of Pharmaceutical Research, 2017openaire +1 more source
INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST: FROM BENCH TO BEDSIDE
Inflammatory Bowel Diseases, 1996A C, Stevens, M, Peppercorn
openaire +2 more sources